Stimulation testing in the first year following thyroid ablation has important prognostic value in thyroid cancer patients. Recombinant human TSH (rhTSH) is better tolerated than thyroid hormone withdrawal but provides only transient stimulation so that the TSH threshold of 30舁mIU·l−1 which defines adequate testing during thyroid hormone withdrawal is not appropriate for rhTSH stimulation. We looked at rhTSH levels after a standard two intramuscular injections of 0.9舁mg rhTSH.
- Body weight
- TSH plasma levels
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging